State of New Jersey Common Pension Fund D’s Jade Biosciences JBIO Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Buy	+9,966	New	+$208K	﹤0.01%	1691

Other funds holding JBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State of New Jersey Common Pension Fund D's JBIO Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Jade Biosciences (JBIO) in Q2 2026: 9,966 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1691 among its holdings.

40 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

State of New Jersey Common Pension Fund D held 9,966 shares of Jade Biosciences worth $221K as of Q2 2026.
Jade Biosciences was a new State of New Jersey Common Pension Fund D position in Q2 2026.
Jade Biosciences made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1691 holding.
40 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.